Japan Lifeline Co., Ltd. Announces Changes in Organizations, Effective on October 1, 2021
September 02, 2021 at 02:10 am EDT
Share
Japan Lifeline Co., Ltd. announced that at the board of directors meeting held on September 2, the Company has decided to make the following changes to its organizations. Changes in the organization structure (Effective on October 1, 2021): (1) Abolish Technical Division of R&D and Manufacturing Headquarters; (2) Newly establish Production Engineering Division under Research & Development Department of R&D and Manufacturing Headquarters;(3) Rename Technical Development Division of Ichihara R&D and Manufacturing Department of R&D and Manufacturing Headquarters to R&D Division.
Japan Lifeline Co., Ltd. is a Japan-based company mainly engaged in the import, manufacture and sale of cardiac circulators and other medical devices. The Company is mainly engaged in the production of rhythm devices, electrophysiological (EP) and ablations, surgical products and intervention products. The rhythm devices include cardiac pacemakers, implantable cardioverter defibrillator (ICD), cardiac resynchronization therapy defibrillator (CRT-D) and other rhythm devices. The EP and ablations include EP catheters for cardiac arrhythmia examination, ablation catheters for arrhythmia treatment and other EP and ablations. The surgical products include prosthetic heart valves and annuloplasty rings for heart disease surgical treatment, vascular grafts, open stent grafts and stent grafts for aortic disease treatment, as well as other surgical products. The intervention products include balloon catheters, guide wires, penetration catheters and other intervention products.
JAPAN LIFELINE CO., LTD. 
